Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 21, 2007; 13(7): 1067-1073
Published online Feb 21, 2007. doi: 10.3748/wjg.v13.i7.1067
Published online Feb 21, 2007. doi: 10.3748/wjg.v13.i7.1067
Table 1 Clinical characteristics of studied patients and the number of transplanted autologous BMCs
| PatientID | Age(yr) | Sex | Etiology ofcirrhosis | BMCs transplanted(n) |
| JWOR | 49 | Male | Alcohol + HCV | 2.8 × 108 |
| FMB | 60 | Male | Alcohol | 5.2 × 108 |
| EAS | 63 | Female | HCV | 3.2 × 108 |
| RNR | 24 | Male | Cholestatic | 13.1 × 108 |
| IAN | 49 | Male | Alcohol + HCV | 2.6 × 108 |
| NPA | 55 | Female | Cryptogenic | 3.5 × 108 |
| RBC | 49 | Male | Alcohol | 4.8 × 108 |
| RMV | 66 | Male | HCV | 3.4 × 108 |
| GAFL | 70 | Male | Alcohol | 1.6 × 108 |
| ABSF | 40 | Male | HCV | 2.4 × 108 |
- Citation: Lyra AC, Soares MBP, Silva LFMD, Fortes MF, Silva AGP, Mota ACA, Oliveira SA, Braga EL, Carvalho WA, Genser B, Santos RRD, Lyra LGC. Feasibility and safety of autologous bone marrow mononuclear cell transplantation in patients with advanced chronic liver disease. World J Gastroenterol 2007; 13(7): 1067-1073
- URL: https://www.wjgnet.com/1007-9327/full/v13/i7/1067.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i7.1067